New lung immuno-oncology therapeutic strategy identified

Researchers at the Icahn School of Medicine at Mount Sinai have demonstrated in a preclinical study a potential new therapeutic approach to treating the most common form of lung cancer.

Leave A Comment

Your email address will not be published. Required fields are marked *